Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products

Author's Avatar
May 21, 2019
Article's Main Image

Potential Transaction Could Result in Near-term Revenues and Funding for Further Clinical Studies